Mh. Mcgowan et al., Na+, K+-ATPase inhibitors down-regulate gene expression of the intracellular signaling protein 14-3-3 in rat lens, J PHARM EXP, 289(3), 1999, pp. 1559-1563
Citations number
42
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
To identify genes that are differentially expressed by Naf, K+-ATPase inhib
itors, we used the differential display technique to compare mRNA expressio
n patterns in rat lens. Lenses were treated with 10 mu M ouabain, bufalin,
or 19-norbufalin derivative for 24 h and were compared with control lenses.
Differential display analysis revealed that one of the downregulated genes
was 14-3-3 theta. Down-regulation was confirmed by Northern blot and by re
verse transcription-polymerase chain reaction analysis. Reverse transcripti
on-polymerase chain reaction of additional 14-3-3 isoforms revealed that th
e eta and gamma isoforms of 14-3-3 are also down-regulated by ouabain, bufa
lin, and 19-norbufalin derivative, whereas the zeta isoform is downregulate
d only by bufalin. Down-regulation of the 14-3-3 isoforms occurred without
a significant change in gamma-crystallin gene expression. These results dem
onstrate that one of the consequences of Na+, K+-ATPase inhibition by exoge
nous or endogenous inhibitors is the down-regulation of mRNA transcripts en
coding several isoforms of 14-3-3. Because the 14-3-3 proteins are multifun
ctional regulatory proteins, the reduction in the abundance of various isof
orms will have profound effects on cell function.